Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GA vs Sedation for Stroke Endovascular Treatment (GASTROKE)
NCT03247998Unknown
- Start
- Aug 2017
- Primary completion
- Aug 2019
- Modality
- Orthosteric Ligands
01
Overview
Randomised, single-blind trial of remifentanil in ischemic stroke (2 arms). Primary endpoint: Randomization potential at 20 weeks. Status: unknown.
02
Drugs
remifentanil
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT03247998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03247998.